ALTIMMUNE, INC. (ALT) ROI
- 2014-09-30: ROI -58.48%.
- 2014-06-30: ROI -91.44%.
- 2014-03-31: ROI -120.94%.
- 2013-12-31: ROI -129.26%.
Complete source-backed roi history.
- Available history
- 2012-03-31 to 2014-09-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2014-09-30 | -58.48% |
| 2014-06-30 | -91.44% |
| 2014-03-31 | -120.94% |
| 2013-12-31 | -129.26% |
| 2013-09-30 | -64.25% |
| 2013-06-30 | -31.30% |
| 2013-03-31 | -35.08% |
| 2012-12-31 | -34.83% |
| 2012-09-30 | -19.35% |
| 2012-06-30 | -17.02% |
| 2012-03-31 | -27.17% |
Annual ROI
| Date | ROI |
|---|---|
| 2013-12-31 | -129.26% |
| 2012-12-31 | -34.83% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |